Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Kath

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl 4-(1-methyl-1H-pyrazol-5-yl)piperidine-1-carboxyl-ateDaniel Richter, John C Kath, Arnold L Rheingold, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
5-Chloro-N-[2-(1H-imidazol-4-yl)eth-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amineDaniel Richter, John C Kath, Arnold L Rheingold, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 28, 2011
5-Bromo-3-(indan-1-yl-oxy)pyridin-2-amineSujin Cho-Schultz, John C Kath, Curtis Moore, et al.
Structure (London, England : 1993)|January 1, 2013
Insights into the aberrant activity of mutant EGFR kinase domain and drug recognitionKetan S Gajiwala, Junli Feng, Roseann Ferre, et al.
Journal of the American Chemical Society|January 5, 2017
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride ProbesQian Zhao, Xiaohu Ouyang, Xiaobo Wan, et al.
The Biochemical Journal|August 14, 2010
Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)Laura R Pearce, Gordon R Alton, Daniel T Richter, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere templateJohn C Kath, Amy P DiRico, Ronald P Gladue, et al.
Biochemical and Biophysical Research Communications|July 16, 2003
Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitorSamit K Bhattacharya, Eric D Cox, John C Kath, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistancePhillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
The Journal of Biological Chemistry|March 31, 2007
Cellular characterization of a novel focal adhesion kinase inhibitorJill K Slack-Davis, Karen H Martin, Robert W Tilghman, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl 4-(1-methyl-1H-pyrazol-5-yl)piperidine-1-carboxyl-ateDaniel Richter, John C Kath, Arnold L Rheingold, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
5-Chloro-N-[2-(1H-imidazol-4-yl)eth-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amineDaniel Richter, John C Kath, Arnold L Rheingold, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 28, 2011
5-Bromo-3-(indan-1-yl-oxy)pyridin-2-amineSujin Cho-Schultz, John C Kath, Curtis Moore, et al.
Structure (London, England : 1993)|January 1, 2013
Insights into the aberrant activity of mutant EGFR kinase domain and drug recognitionKetan S Gajiwala, Junli Feng, Roseann Ferre, et al.
Journal of the American Chemical Society|January 5, 2017
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride ProbesQian Zhao, Xiaohu Ouyang, Xiaobo Wan, et al.
The Biochemical Journal|August 14, 2010
Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)Laura R Pearce, Gordon R Alton, Daniel T Richter, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere templateJohn C Kath, Amy P DiRico, Ronald P Gladue, et al.
Biochemical and Biophysical Research Communications|July 16, 2003
Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitorSamit K Bhattacharya, Eric D Cox, John C Kath, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistancePhillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
The Journal of Biological Chemistry|March 31, 2007
Cellular characterization of a novel focal adhesion kinase inhibitorJill K Slack-Davis, Karen H Martin, Robert W Tilghman, et al.
Pageof 3